GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (LTS:0IMT) » Definitions » Price-to-Owner-Earnings

PhotoCure ASA (LTS:0IMT) Price-to-Owner-Earnings : 135.00 (As of Jun. 25, 2024)


View and export this data going back to 2008. Start your Free Trial

What is PhotoCure ASA Price-to-Owner-Earnings?

As of today (2024-06-25), PhotoCure ASA's share price is kr62.10. PhotoCure ASA's Owner Earnings per Share (TTM) ended in Mar. 2024 was kr0.46. It's Price-to-Owner-Earnings for today is 135.00.


The historical rank and industry rank for PhotoCure ASA's Price-to-Owner-Earnings or its related term are showing as below:

LTS:0IMT' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 32.99   Med: 253.46   Max: 1927.78
Current: 136.36

During the past 13 years, the highest Price-to-Owner-Earnings of PhotoCure ASA was 1927.78. The lowest was 32.99. And the median was 253.46.


LTS:0IMT's Price-to-Owner-Earnings is ranked worse than
93.44% of 427 companies
in the Drug Manufacturers industry
Industry Median: 24.5 vs LTS:0IMT: 136.36

As of today (2024-06-25), PhotoCure ASA's share price is kr62.10. PhotoCure ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.18. Therefore, PhotoCure ASA's PE Ratio for today is 345.00.

As of today (2024-06-25), PhotoCure ASA's share price is kr62.10. PhotoCure ASA's EPS without NRI for the trailing twelve months (TTM) ended in was kr0.18. Therefore, PhotoCure ASA's PE Ratio without NRI for today is 345.00.

During the past 13 years, PhotoCure ASA's highest PE Ratio without NRI was 1700.00. The lowest was 18.92. And the median was 102.81.


PhotoCure ASA Price-to-Owner-Earnings Historical Data

The historical data trend for PhotoCure ASA's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Price-to-Owner-Earnings Chart

PhotoCure ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 994.44 577.47 - - 395.88

PhotoCure ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 395.88 122.61

Competitive Comparison of PhotoCure ASA's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhotoCure ASA's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where PhotoCure ASA's Price-to-Owner-Earnings falls into.



PhotoCure ASA Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

PhotoCure ASA's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=62.10/0.46
=135.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PhotoCure ASA  (LTS:0IMT) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


PhotoCure ASA Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of PhotoCure ASA's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


PhotoCure ASA (LTS:0IMT) Business Description

Traded in Other Exchanges
Address
Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, Netherlands, Other European countries, and the United States.

PhotoCure ASA (LTS:0IMT) Headlines

No Headlines